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Secretory immunoglobulin A (S-IgA) antibodies have a 
central role in anti-Giardial defence. It has been 
demonstrated that transforming growth factor-beta1 
(TGF-b1) stimulates B lymphocytes to produce and 
secrete S-IgA. We sought to determine the association 
between TGF-b1 polymorphism (T+869C) with suscep­
tibility to Giardiasis. The TGF-b1 genotypes and levels 
of salivary (S-IgA) were analysed in individuals with 
Giardiasis (97 symptomatic and 57 asymptomatic) and 
controls (n = 92). Individuals with symptomatic Giar­
diasis had the lowest levels of S-IgA compared to 
individuals in asymptomatic Giardiasis and control 
groups (97%, 73% and 43%, <1 g L)1, respectively, 
P = 0.002). The frequency of allele C and CC genotypes 
of TGF-b1 polymorphism was significantly higher 
among symptomatic patients than asymptomatic and 
control groups. Logistic regression analysis demon­
strated that the individuals homozygous for allele C of 
TGF-b1 had a significantly higher risk for symptomatic 
Giardiasis with odds ratio of 2.76 (95% CI: 3.88, 1.71, 
P = 0.007). Among the participants with TT genotype 
per cent of individuals with S-IgA level of more than 
1 g L)1 was almost twice the percentage in CC genotype 
individuals (14% versus 7% respectively P = 0.01). Our 
data suggest that CC genotype of TGF-b1 polymor­
phism at codon 10 is associated with occurrence of 
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The protozoan parasite Giardia lamblia is an intestinal 
parasite of humans, which the World Health Organi­
zation (1992) estimates to have infected 250 million 
people worldwide. This protozoan pathogen colonizes 
small intestine and can attach to the epithelium but 
does not invade the mucosa. Infections are normally 
self-limiting, as immunocompetent hosts can control 
and typically eradicate G. lamblia, a process that 
involves CD4 T cells and the generation of secretory 
immunoglobulin A (S-IgA) and other, poorly under­
stood effectors (Faubert, 2000; Singer & Nash, 2000; 
Langford et al., 2002; Eckmann, 2003). Despite the 
clinical symptoms, diarrhoea, abdominal pain, malab­
sorption and weight loss, infection is not accompanied 
by signiﬁcant mucosal inﬂammation (Oberhuber et al., 
1997). Role of transforming growth factor-beta1 
(TGF-b1) in intestinal parasitic infections has attracted 
signiﬁcant attention, as in vitro tests showed that 
TGF-b1 stimulates the isotype switch to IgA, as well 
as IgA secretion by LPS-stimulated mIgA)B cells from 
Peyer’s patches and spleen (Sonoda et al., 1989, Coff­
man et al., 1998). To date, several TGF-b1 polymor­
phisms have been identiﬁed among these, two are 
located in exon 1 changing the amino acid sequence of 
the signal peptide (at positions +869 and +915) result­
ing in variations of codon 10 or codon 25, respec­
tively. The third polymorphism in codon 263 (in exon 
5) results in the amino acid substitution threonine to 
isoleucine in the precursor part of the protein. The 
TGF-ß1 polymorphism (+869 in codon 10) is a T to C 
transition at nucleotide 29 located in the hydrophobic 
core of the signal peptide, resulting in the replacement 
of a hydrophobic leucine with a small, neutral proline 
(Cambien et al., 1996). Such a substitution would 
change the overall hydrophobicity of the core trans­
port sequence and disrupt the alpha-helical structure 
of the region, therefore altering its ability to direct 
protein transport across the endoplasmic reticulum 
(Randall & Hardy, 1989). It has been shown that the 
production of TGF-b1 is associated with some poly­
morphisms of the gene (Awad et al., 1998). A correla­
tion between the polymorphism of C+915G and the 
concentration of TGF-b in human serum has been 6, 345–349 345 
346 H. Taherkhani et al. shown (Grainger et al., 1999). These ﬁndings indicate 
that the TGF-b1 polymorphisms may be involved in the 
modulation of expression of the TGF-b1 gene and there­
fore a predisposing factor for Giardiasis could be linked 
to the particular alleles of this gene. Data regarding the 
association of TGF-b1 T+869C polymorphism and 
S-IgA is controversial. In addition, no previous study 
investigated the role of TGF-b1 polymorphism in 
susceptibility to Giardiasis. 
Giardiasis is quite common among Iranian popula­
tion. A national survey of the prevalence of intestinal 
parasitic infections in Iran revealed that from 53 995 
people aged 2+ years (12 495 families), 10.9% were 
infected with Giardia (Sayyari et al., 2005) The infec­
tion rate was highest in the 2–14 years age group 
(25.5%) and in rural residents (23.7%). 
The purpose of this study was to determine the asso­
ciation between polymorphism of TGF-b1 at codon 10 
and susceptibility to Giardiasis in Iranian population. 
The association of levels of S-IgA and the genotypes of 
TGF-b1 at codon 10 were also assessed. In addition, 
the role of polymorphisms in TGF-b1 gene and levels 
of S-IgA in development of symptom among patients 
with Giardiasis were evaluated. We, for the ﬁrst 
time, found an association between CC genotype of 
TGF-b1 T+869C polymorphism and susceptibility to 
Giardiasis. Materials and methods 
The population under study was 97 patients with 
symptomatic Giardiasis (49 men and 48 women) who 
referred to Sina and Ekbatan hospitals in Hamadan 
province, Southwest of Iran between the years of 2006 
and 2008. A group of 51 individuals (27 men and 24 
women) recruited from the hospitals personnel and 
their family members who had G. lamblia in their 
stool examination without any symptoms. This group 
was chosen from 543 individuals underwent annual 
check-up for parasitic intestinal infection. The control 
group consisted of 92 volunteer individuals (48 men 
and 44 women) recruited from the same hospitals with 
a negative test result for Giardiasis. Informed consent 
was obtained from each subject. The Ethical Commit­
tee of Hamadan University of Medical Sciences 
approved the study protocol. Diagnostic criteria were 
as follows: positive stool examination smears in direct 
smear or after formalin ether concentration (at least 
one of three times). Individuals with G. lamblia 
divided into two groups, symptomatic that had at least 
one of the symptoms (diarrhoea, steatorrhoea, gastro­
intestinal discomfort, malabsorption and weight loss) 
and asymptomatic that had only cyst in the stool. 
Blood samples were treated with sucrose lysis buffer 
and mononuclear layer of peripheral blood was har­
vested and the cell pellet stored at )80 °C until DNA 
extraction. Genomic DNA was extracted from EDTA-
treated peripheral blood by the standard method 
(Miller et al., 1998). ª 2009 BlackweGenotyping 
Ampliﬁcation refractory mutation system–polymerase 
chain reaction (ARMS-PCR) method was used to 
genotype individual samples for the TGF-b1 polymor­
phisms under investigation using primers as already 
described (Perrey et al., 1999). Fragments containing 
the single nucleotide polymorphism T+869C were 
ampliﬁed by ARMS-PCR. The primers for detection of 
polymorphism at nucleotide acid +869 were 
5¢-GCAGCGGTAGCAGCAGCG-3¢ (C allele speciﬁc), 
5¢-AGCAGCGGTAGCAGCAGCA-3¢ (T allele speciﬁc) 
and 5¢-TCCGTGGGATACTGAGACAC-3¢ (generic 
primer); and the generated PCR product size was 
241 bp. We used internal control primer 1 (HGH for­
ward), 5¢-GCCTTCCCAACCATTCCCTTA-3¢; and 
the internal control primer 2 (HGH reverse), 5¢­
TCACGGATTTCTGTTGTGTTTC-3¢. The internal 
control primers were used to amplify a segment of 
human growth hormone gene to check for successful 
PCR ampliﬁcation. Ampliﬁcation was carried out 
using a PCR Techne Flexigene apparatus (Roche, 
Mannheim, Germany) in a total volume of 15 lL that 
contained 100 ng of genomic DNA, each primer pair 
consisting of 2 lmol of allele speciﬁc and 0.5 lmol of 
common primers, 200 lmol L)1 each dNTP; 10 mM 
Tris–HC1 (pH 8.3); 50 mM KCI, 1.5 mM MgCl2 and 
0.5 IU Taq DNA polymerase. PCR performed without 
DNA template represented the negative control. The 
reaction was carried out as follow; initial denaturation 
was 94 °C for 2 min, followed by ten cycles of ampli­
ﬁcation at 96 °C for 20 s and annealing at 62 °C for 
50 s, followed by 20 cycles of denaturation at 96 °C 
for 20 s and annealing at 60 °C for 50 s, with exten­
sion for 40 s at 72 °C, and then with ﬁnal soak at 
10 °C. The ampliﬁed PCR products were analyses by 
2% agarose gel electrophoresis followed by 
0.5 lg mL)1 ethidium bromide staining and ultraviolet 
visualization. Measurement of total salivary IgA 
Saliva ﬂow was stimulated by chewing a single Para-
ﬁlm (5 cm2) section for 1 min, which typically elicits 
1–3 mL min)1 of ﬂow. Subjects were encouraged to 
allow the saliva to accumulate in the mouth until the 
urge to swallow occurred. Without expectorating, the 
subjects allowed the saliva to ﬂow into the collection 
tube and repeated the entire process until time elapsed. 
The sample was immediately placed on ice and then 
centrifuged to remove cellular debris. The supernatant 
ﬂuid was frozen at )80 °C for later analysis of total 
IgA by an immunonephelometric technique (Minineph, 
The Binding Site, Oxford, UK) used as instructed by 
the manufacturer. 
Brieﬂy, total IgA in plasma were analyzed using 
enzyme-linked immunosorbent assays performed in 
96-well plates. Plates were coated with anti-IgA (ICN, 
Costa Mesa, CA, USA) at 10 lg mL)1. The reaction ll Publishing Ltd, International Journal of Immunogenetics 36, 345–349 
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Table 2. Alleles and genotype frequencies in control subjects and 
individuals with Giardiasis 
TGF-b1 
polymorphism 
Symptomatic 
patients 
Asymtomatic 
patients Control P-value 
Alleles, n (%) 
C allele 103 (53.1) 44 (43.1) 80 (43.5) 0.001 was revealed anti-human IgA-peroxidase-conjugated 
(Sigma, St. Louis, MO, USA) (1 ⁄2000). IgA concentra­
tion was extrapolated from a reference curve generated 
by assaying dilutions of a pool of plasma specimens 
from blood donors whose subclass concentrations were 
determined by an immunonephelometric technique 
(Minineph). T allele 91 (46.9) 58 (56.9) 104 (56.5) 
Genotype, n (%) 
CC 39 (40.2) 8 (15.7) 20 (21.7) 0.005 
CT 25 (25.8) 28 (55) 40 (43.5) 
TT 33 (34) 15 (29.3) 32 (34.8) 
TGF-b1, transforming growth factor-beta1. Statistical analysis 
The data were analysed by constructing contingency 
tables to determine differences in genotypic frequencies 
of the relevant polymorphisms in patients and con­
trols. P-values for association studies were calculated 
using the chi-square test and one-way analysis of vari­
ances (ANOVA). Results of the logistic regression model 
were expressed as odds ratio (OR) and 95% CI. All 
P-values were evaluated in a two-sided model, and 
P < 0.05 was considered statistically signiﬁcant. Chi-
square (v 2) test was used to determine the signiﬁcance 
of differences from the Hardy–Weinberg equilibrium. 
Statistical analysis was performed using the SPSS 13.0 
software package (SPSS, Chicago, IL, USA). Results 
There was no signiﬁcant difference between the ages 
of symptomatic patients, asymptomatic individuals 
and the controls (Mean ± SD, 35 ± 4, 37 ± 6, 34 ± 5, 
respectively). The ratio of male ⁄ female also was not 
signiﬁcantly different between the groups. The levels 
of total S-IgA in the patients and control groups are 
shown in Table 1. Because the frequency distribution 
of S-IgA was not a Gaussian distribution, we divided 
the levels into two groups to make the data more com­
parable. The individuals with symptomatic Giardiasis 
had a lower level of S-IgA compared to individuals in 
asymptomatic Giardiasis and control groups. The level 
of S-IgA in 97% of the symptomatic patients were 
<1 g )L 1 in contrast to 73% and 42% in asymptom­
atic and control group (P = 0.002). The frequency of 
TGF-b1 polymorphism in codon 10 was assessed in 
patients and controls. The observed genotype counts 
were not signiﬁcantly different from those expected 
under Hardy–Weinberg equilibrium (veriﬁed by chi-
square test). As indicated in Table 2 prevalence of 
allele C was signiﬁcantly higher in the symptomatic 
patients in comparison with the asymptomatic and the 
control groups (P = 0.001). The control and asymp­
tomatic groups also had higher frequency of T allele Table 1. Levels of salivary IgA in individuals with symptomatic and 
asymptomatic Giardiasis and control group 
Salivary IgA Symptomatic Asymptomatic 
g L)1 infected infected Control 
0.19–0.99 94 (96.9%) 37 (72.5%) 39 (42.5%) 
1–4 3 (3.1%) 14 (27.5%) 53 (57.5%) 
ª 2009 Blackwell Publishing Ltd, International Journal of Immunogenetics 3than the symptomatic patients. The distribution of 
TGF-b1 genotypes for codon 10 polymorphism was 
also different among the groups. The CC genotype 
was signiﬁcantly higher among the symptomatic 
patients than the other two groups (P = 0.005). While 
the distribution of TT genotype did not show signiﬁ-
cant difference, the control and asymptomatic patients 
had a higher frequency of CT genotypes in comparison 
with the symptomatic patients. Multiple logistic regres-
sion analysis controlled for sex and age demonstrated 
that homozygous genotype of allele C of TGF-b1 
polymorphism is an independent risk factor for con-
tracting Giardiasis (OR: 2.76, 95% CI: 3.88, 1.71, 
P = 0.007). 
Table 3 compares the levels of total S-IgA among 
individuals with CC, CT and TT genotypes of TGF-b1 
T+869C. The levels of S-IgA )  were <1 g L 1 in more 
than 74% of participants and only 26% showed a 
concentration of )more than 1 g L 1 . Among the par-
ticipants with TT genotype per cent of individuals 
with S-IgA level of more than 1 g )L 1 was almost 
twice the percentage in CC genotype individuals (14% 
versus 7%, respectively, P = 0.01). This per cent 
appears to be 42% for individuals with the heterozy­
gous genotype. Discussion 
Our study provides evidence for an association 
between TGF-b1 T+869C polymorphism and suscepti­
bility to Giardiasis. We found that the prevalence of 
allele C and CC genotypes of TGF-b1 T+869C 
polymorphism was signiﬁcantly higher in the patients 
with symptomatic Giardiasis and these patients had 
signiﬁcantly lower levels of S-IgA compared to the Table 3. Levels of salivary IgA among individuals with CC, TC and 
TT genotypes of TGF-b1 T+869C polymorphism 
Salivary IgA 
g L)1 CC genotype TC genotype TT genotype 
0.19–0.99 53 (92.5%) 60 (58.2%) 69 (86.2%) 
1–4 4 (7.5%) 43 (41.8%) 11 (13.8%) 
6, 345–349 
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data suggest that individuals with TC or TT genotypes 
are more likely to have high levels of total S-IgA. 
Several studies suggest an important role for B cells in 
clearing Giardia infection. For example, infections of 
humans with G. lamblia or of mice with Giardia muris 
result in the production of anti-Giardial antibodies of 
the IgA, IgM and IgG isotypes in mucosal secretions 
and serum. The speciﬁc antibody production correlates 
with Giardial clearance (Daniels & Belosevic, 1994; 
Faubert, 2000). Such antibodies reach their targets 
in vivo, since anti-Giardial IgA and IgG antibodies coat 
trophozoites in Giardia-infected mice. Mice depleted of 
B cells by treatment with anti-IgM antibodies and mice 
with X-linked immunodeﬁciency, which have a defect 
in B-cell development and function, are unable to clear 
G. muris infection (Snider et al., 1985, 1988). In con­
trast, other data suggest that B cells have only a limited 
role in anti-Giardial immunity (Zhou et al., 2003). For 
example, mice with X-linked immunodeﬁciency can 
develop acquired immunity against secondary challenge 
with G. muris (Skea & Underdown, 1991). These data 
suggest that B-cell-independent host defences against 
Giardia may play an important role in controlling and 
clearing infection. 
Our study is the ﬁrst that investigates the role of 
TGF-b1 polymorphism in susceptibility to Giardiasis. 
We demonstrated that the CC genotype of TGF-b1 
was a susceptibility factor for contracting Giardiasis 
among Iranian population. The association between 
the C allele and scleroderm has been reported (Crilly 
et al., 2002). The proline allele at codon 10 has also 
been linked to bone mineral density (Yamada et al., 
1998) regulation of blood pressure (Rivera et al., 
2001) and diabetic nephropathy (Wong et al., 2003). 
Currently, it is not clear whether a leucine or pro-
line at amino acid position 10 of the signalling 
sequence of the TGF-b1 gene results in high active 
TGF-b1 concentrations in vivo. Awad et al. (1998) 
reported that patients with cystic ﬁbrosis with a leu­
cine residue at codon 10 (allele C) have elevated circu­
lating levels of TGF-b1, whereas Yamada et al. (1998) 
showed that Japanese women with osteoporosis who 
have a Proline residue at this position (allele T) have 
the highest TGF-b1 serum levels. The association of 
proline allele at codon 10 with high level of TGF-b1 
has been reported by other investigators (Suthanthiran 
et al., 2000) 
In our study the patients with symptomatic Giardia­
sis showed lower levels of total S-IgA. We did not 
measure the speciﬁc S-IgA against Giardia. However, a 
correlation between total S-IgA and speciﬁc anti-Giar­
dia S-IgA has been reported in children infected with 
Giardiasis (Rodriguez et al., 2004). It has been demon­
strated that the levels of S-IgA are elevated in the mice 
infected with Giardia. The same group showed that 
IgA-deﬁcient mice could not eradicate Giardia infec­
tion, demonstrating that IgA is required for the parasite 
clearance (Langford et al., 2002). ª 2009 BlackweIt seems that the level of S-IgA in the person’s ﬁrst 
contact with the parasite is in a low level and after 
some time, with the activity of the immune system and 
other involved cytokines (including TGF-b1), the level 
of S-IgA increases (Faubert, 2000; Thompson, 2000). 
In our study, the symptomatic patients with lower 
levels of S-IgA might be in their early phases of the 
infection and thus produce lower levels of S-IgA. This 
weak reaction might be also related to a defect in 
symptomatic patients in their response to pathogen. In 
support of this notion, an impaired IgA response to 
Giardia antigen has been reported in children with 
persistent diarrhoea and Giardiasis (Char et al., 
1993). Furthermore, these individuals carry CC geno­
type of TGF-b1 and this genotype has been reported 
to be associated with lower levels of TGF-b (Yamada 
et al., 1998; Suthanthiran et al., 2000). Therefore, 
one can speculate that levels of S-IgA in the symptom­
atic patients might be lower than the other groups due 
to a reduced stimulatory effect of TGF-b1 on S-IgA 
secretion. As we did not measure serum levels of TGF-
b in our patients, cautious interpretation of the data is 
needed. The future studies will help us to shed light in 
this issue. The lower levels of S-IgA in the symptom­
atic patients might also contribute to the severity of 
the disease by reducing the power of immune system 
for clearing the parasite. In support of this, in our study 
the levels of S-IgA in individuals with asymptomatic 
Giardiasis were close to those in the control group and 
not to those of symptomatic patients. In addition, like 
the control group, the frequency of T allele and CT 
genotype were also higher in the asymptomatic group 
than the symptomatic patients. However, the associa­
tion between CC genotype of TGF-b1 and Giardiasis 
can be attributed to linkage disequilibrium. The CC 
genotype may lead to the lower levels of IgA and may 
also control symptomatic Giardiasis through association 
with other genes that control symptomatic Giardiasis. 
The results of our study need to be replicated by 
others to ensure that the genetic association can be 
applied to several different populations of people 
exposed to Giardia. Conclusion 
Our ﬁndings suggest an association between TGF-b1 
polymorphism and susceptibility to Giardiasis in 
Iranian patients. References 
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